文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于眼部疾病局部给药的纳米凝胶研究进展

Advances in Nanogels for Topical Drug Delivery in Ocular Diseases.

作者信息

Wu Yongkang, Tao Qing, Xie Jing, Lu Lili, Xie Xiuli, Zhang Yang, Jin Yong

机构信息

School of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei 230032, China.

出版信息

Gels. 2023 Apr 2;9(4):292. doi: 10.3390/gels9040292.


DOI:10.3390/gels9040292
PMID:37102904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10137933/
Abstract

Nanotechnology has accelerated the development of the pharmaceutical and medical technology fields, and nanogels for ocular applications have proven to be a promising therapeutic strategy. Traditional ocular preparations are restricted by the anatomical and physiological barriers of the eye, resulting in a short retention time and low drug bioavailability, which is a significant challenge for physicians, patients, and pharmacists. Nanogels, however, have the ability to encapsulate drugs within three-dimensional crosslinked polymeric networks and, through specific structural designs and distinct methods of preparation, achieve the controlled and sustained delivery of loaded drugs, increasing patient compliance and therapeutic efficiency. In addition, nanogels have higher drug-loading capacity and biocompatibility than other nanocarriers. In this review, the main focus is on the applications of nanogels for ocular diseases, whose preparations and stimuli-responsive behaviors are briefly described. The current comprehension of topical drug delivery will be improved by focusing on the advances of nanogels in typical ocular diseases, including glaucoma, cataracts, dry eye syndrome, and bacterial keratitis, as well as related drug-loaded contact lenses and natural active substances.

摘要

纳米技术加速了制药和医疗技术领域的发展,用于眼部应用的纳米凝胶已被证明是一种很有前景的治疗策略。传统的眼部制剂受到眼部解剖和生理屏障的限制,导致药物保留时间短和生物利用度低,这对医生、患者和药剂师来说都是一个重大挑战。然而,纳米凝胶能够将药物包裹在三维交联聚合物网络中,并通过特定的结构设计和独特的制备方法,实现所载药物的控释和缓释,提高患者的依从性和治疗效率。此外,纳米凝胶比其他纳米载体具有更高的载药能力和生物相容性。在这篇综述中,主要关注纳米凝胶在眼部疾病中的应用,简要描述了其制备方法和刺激响应行为。通过关注纳米凝胶在典型眼部疾病(包括青光眼、白内障、干眼症和细菌性角膜炎)以及相关载药隐形眼镜和天然活性物质方面的进展,将增进对局部给药的当前理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/7423654a7a99/gels-09-00292-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/279b62a5dd85/gels-09-00292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/d97001ef629b/gels-09-00292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/89943fabee74/gels-09-00292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/80f8d4bf322a/gels-09-00292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/0c79fb5e5216/gels-09-00292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/7423654a7a99/gels-09-00292-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/279b62a5dd85/gels-09-00292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/d97001ef629b/gels-09-00292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/89943fabee74/gels-09-00292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/80f8d4bf322a/gels-09-00292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/0c79fb5e5216/gels-09-00292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc1f/10137933/7423654a7a99/gels-09-00292-g006.jpg

相似文献

[1]
Advances in Nanogels for Topical Drug Delivery in Ocular Diseases.

Gels. 2023-4-2

[2]
Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders.

Curr Drug Res Rev. 2024

[3]
Chemical, physical, and biological stimuli-responsive nanogels for biomedical applications (mechanisms, concepts, and advancements): A review.

Int J Biol Macromol. 2023-1-31

[4]
Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.

Int J Mol Sci. 2021-11-16

[5]
Hydrogel-based ocular drug delivery systems for hydrophobic drugs.

Eur J Pharm Sci. 2020-11-1

[6]
Nanogel-based Transdermal Drug Delivery System: A Therapeutic Strategy with Under Discussed Potential.

Curr Top Med Chem. 2023

[7]
Stimulus-responsive polymeric nanogels as smart drug delivery systems.

Acta Biomater. 2019-5-13

[8]
Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels.

Acta Biomater. 2022-3-15

[9]
Contact lenses as drug-delivery systems: a promising therapeutic tool.

Arch Soc Esp Oftalmol (Engl Ed). 2020-1

[10]
A review of polymeric colloidal nanogels in transdermal drug delivery.

Curr Pharm Des. 2015

引用本文的文献

[1]
Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases.

Discov Nano. 2025-5-3

[2]
Current perspectives in tackling glaucoma blindness.

Indian J Ophthalmol. 2025-3-1

[3]
Transforming Medicine with Nanobiotechnology: Nanocarriers and Their Biomedical Applications.

Pharmaceutics. 2024-8-23

[4]
Nanomedicine in glaucoma treatment; Current challenges and future perspectives.

Mater Today Bio. 2024-9-4

[5]
Nanogels: Recent Advances in Synthesis and Biomedical Applications.

Nanomaterials (Basel). 2024-8-1

[6]
Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications.

J Lipids. 2024-7-10

[7]
Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease.

Nanomaterials (Basel). 2024-4-12

[8]
Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders.

Curr Drug Res Rev. 2024

[9]
Recent advancements in nanomaterial-laden contact lenses for diagnosis and treatment of glaucoma, review and update.

J Nanobiotechnology. 2023-11-2

[10]
Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases.

Pharmaceutics. 2023-7-22

本文引用的文献

[1]
Ocular Drug Delivery: a Comprehensive Review.

AAPS PharmSciTech. 2023-2-14

[2]
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.

J Control Release. 2023-2

[3]
Biomedicine Innovations and Its Nanohydrogel Classifications.

Pharmaceutics. 2022-12-18

[4]
Recent Advances in the Biomedical Applications of Functionalized Nanogels.

Pharmaceutics. 2022-12-16

[5]
Chemical, physical, and biological stimuli-responsive nanogels for biomedical applications (mechanisms, concepts, and advancements): A review.

Int J Biol Macromol. 2023-1-31

[6]
Cationic liposomes as promising vehicles for timolol/brimonidine combination ocular delivery in glaucoma: formulation development and in vitro/in vivo evaluation.

Drug Deliv Transl Res. 2023-4

[7]
Temperature-Dependent Nanogel for Pesticide Smart Delivery with Improved Foliar Dispersion and Bioactivity for Efficient Control of Multiple Pests.

ACS Nano. 2022-12-27

[8]
Development and biological evaluation of pNIPAM-based nanogels as vaccine carriers.

Int J Pharm. 2023-1-5

[9]
The Development and Evaluation of Phase Transition Microemulsion for Ocular Delivery of Acetazolamide for Glaucoma Treatment.

AAPS PharmSciTech. 2022-11-23

[10]
Ocular barriers as a double-edged sword: preventing and facilitating drug delivery to the retina.

Drug Deliv Transl Res. 2023-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索